Fatty acid concentrations in patients with posttraumatic stress disorder compared to healthy controls

Journal of Affective Disorders

Volumn 205, Issue , 2016, Pages 351-359

  de Vries, Giel Jan ^a   Mocking, Roel ^a   Lok, Anja ^a   Assies, Johanna ^a   Schene, Aart ^b,c   Olff, Miranda ^a,d  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY   (Netherlands)

^d ARQ PSYCHOTRAUMA EXPERT GROUP   (Netherlands)

Author keywords

Monounsaturated fatty acids; Omega 3; Omega 6; PTSD; Trauma

Indexed keywords

ARACHIDIC ACID; ARACHIDONIC ACID; BEHENIC ACID; DOCOSADIENOIC ACID; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; DOCOSATETRAENOIC ACID; EICOSADIENOIC ACID; ERUCIC ACID; FATTY ACID; GAMMA LINOLENIC ACID; GONDOIC ACID; HOMO GAMMA LINOLENIC ACID; HYPOGEIC ACID; ICOSAPENTAENOIC ACID; ICOSATRIENOIC ACID; LIGNOCERIC ACID; LINOLEIC ACID; LINOLENIC ACID; MYRISTIC ACID; NERVONIC ACID; OLEIC ACID; PALMITIC ACID; PALMITOLEIC ACID; STEARIC ACID; UNCLASSIFIED DRUG; VACCENIC ACID; UNSATURATED FATTY ACID;

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIETARY INTAKE; ERYTHROCYTE; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NUTRITIONAL ASSESSMENT; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; BLOOD; CASE CONTROL STUDY;

CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; MALE; MIDDLE AGED; STRESS DISORDERS, POST-TRAUMATIC;

EID: 84983407828     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2016.08.021     Document Type: Article

References (90)

1. Ahmadi, N., Hajsadeghi, F., Mirshkarlo, H.B., Budoff, M., Yehuda, R., Ebrahimi, R., Post-traumatic stress disorder, coronary atherosclerosis, and mortality. Am. J. Cardiol. 108 (2011), 29–33.
2. Assies, J., Mocking, R.J., Lok, A., Ruhe, H.G., Pouwer, F., Schene, A.H., Effects of oxidative stress on fatty acid- and one-carbon-metabolism in psychiatric and cardiovascular disease comorbidity. Acta Psychiatr. Scand. 130 (2014), 163–180.
3. Assies, J., Mocking, R.J., Pouwer, F., Maternal depression and child development after prenatal DHA supplementation. JAMA 305 (2011), 360–361.
4. Assies, J., Pouwer, F., Lok, A., Mocking, R.J., Bockting, C.L., Visser, I., Abeling, N.G., Duran, M., Schene, A.H., Plasma and erythrocyte fatty acid patterns in patients with recurrent depression: a matched case-control study. PLoS One, 5, 2010, e10635.
5. Baker, D.G., Nievergelt, C.M., O'Connor, D.T., Biomarkers of PTSD: neuropeptides and immune signaling. Neuropharmacology 62 (2012), 663–673.
6. Baxter, A.J., Vos, T., Scott, K.M., Ferrari, A.J., Whiteford, H.A., The global burden of anxiety disorders in 2010. Psychol. Med., 2014, 1–12.
7. Beck, A.T., Beamesderfer, A., Assessment of depression: the depression inventory. Mod. Probl. Pharm. 7 (1974), 151–169.
8. Beltz, B.S., Tlusty, M.F., Benton, J.L., Sandeman, D.C., Omega-3 fatty acids upregulate adult neurogenesis. Neurosci. Lett. 415 (2007), 154–158.
9. Bender, R., Lange, S., Adjusting for multiple testing–when and how?. J. Clin. Epidemiol. 54 (2001), 343–349.
10. Bitencourt, R.M., Pamplona, F.A., Takahashi, R.N., Corticosteroid-endocannabinoid loop supports decrease of fear-conditioned response in rats. Eur. Neuropsychopharmacol. 24 (2014), 1091–1102.
11. Bourre, J.M., Dietary omega-3 Fatty acids and psychiatry: mood, behaviour, stress, depression, dementia and aging. J. Nutr. Health Aging 9 (2005), 31–38.
12. Calderon, F., Kim, H.Y., Docosahexaenoic acid promotes neurite growth in hippocampal neurons. J. Neurochem. 90 (2004), 979–988.
13. Christopher, M., A broader view of trauma: a biopsychosocial-evolutionary view of the role of the traumatic stress response in the emergence of pathology and/or growth. Clin. Psychol. Rev. 24 (2004), 75–98.
14. Conklin, S.M., Gianaros, P.J., Brown, S.M., Yao, J.K., Hariri, A.R., Manuck, S.B., Muldoon, M.F., Long-chain omega-3 fatty acid intake is associated positively with corticolimbic gray matter volume in healthy adults. Neurosci. Lett. 421 (2007), 209–212.
15. Creamer, M., Bell, R., Failla, S., Psychometric properties of the impact of event scale – revised. Behav. Res. Ther. 41 (2003), 1489–1496.
16. Crum-Cianflone, N.F., Bagnell, M.E., Schaller, E., Boyko, E.J., Smith, B., Maynard, C., Ulmer, C.S., Vernalis, M., Smith, T.C., Impact of combat deployment and posttraumatic stress disorder on newly reported coronary heart disease among US active duty and reserve forces. Circulation 129 (2014), 1813–1820.
17. Daniels, J.K., Lamke, J.P., Gaebler, M., Walter, H., Scheel, M., White matter integrity and its relationship to PTSD and childhood trauma–a systematic review and meta-analysis. Depress Anxiety 30 (2013), 207–216.
18. Davidson, J., Smith, R., Kudler, H., Validity and reliability of the DSM-III criteria for posttraumatic stress disorder. Experience with a structured interview. J. Nerv. Ment. Dis. 177 (1989), 336–341.
19. de Vries, G.J., Olff, M., The lifetime prevalence of traumatic events and posttraumatic stress disorder in the Netherlands. J. Trauma Stress 22 (2009), 259–267.
20. Delarue, J., Matzinger, O., Binnert, C., Schneiter, P., Chiolero, R., Tappy, L., Fish oil prevents the adrenal activation elicited by mental stress in healthy men. Diabetes Metab. 29 (2003), 289–295.
21. Donders, A.R., van der Heijden, G.J., Stijnen, T., Moons, K.G., Review: a gentle introduction to imputation of missing values. J. Clin. Epidemiol. 59 (2006), 1087–1091.
22. First, M.B. Spitzer, R.L., Gibbon, M., Williams, J.B.W., 2002. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P). Biometrics Research, New York State Psychiatric Institute, New York.
23. Frijling, J.L., van Zuiden, M., Koch, S.B., Nawijn, L., Goslings, J.C., Luitse, J.S., Biesheuvel, T.H., Honig, A., Bakker, F.C., Denys, D., Veltman, D.J., Olff, M., Efficacy of oxytocin administration early after psychotrauma in preventing the development of PTSD: study protocol of a randomized controlled trial. BMC Psychiatry, 14, 2014, 92.
24. Frijling, J.L., Zuiden, M.V., Koch, S.B., Nawijn, L., Veltman, D.J., Olff, M., Effects of intranasal oxytocin on amygdala reactivity to emotional faces in recently trauma-exposed individuals. Soc. Cogn. Affect Neurosci., 2015.
25. Graham, J.W., Missing data analysis: making it work in the real world. Annu Rev. Psychol. 60 (2009), 549–576.
26. Hallahan, B., Garland, M.R., Essential fatty acids and mental health. Br. J. Psychiatry 186 (2005), 275–277.
27. Hamazaki, K., Itomura, M., Huan, M., Nishizawa, H., Sawazaki, S., Tanouchi, M., Watanabe, S., Hamazaki, T., Terasawa, K., Yazawa, K., Effect of omega-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers: a randomized, placebo-controlled, double-blind trial. Nutrition 21 (2005), 705–710.
28. Imamura, F., Lemaitre, R.N., King, I.B., Song, X., Steffen, L.M., Folsom, A.R., Siscovick, D.S., Mozaffarian, D., Long-chain monounsaturated Fatty acids and incidence of congestive heart failure in 2 prospective cohorts. Circulation 127 (2013), 1512–1518.
29. Irmisch, G., Schlafke, D., Richter, J., Relationships between fatty acids and psychophysiological parameters in depressive inpatients under experimentally induced stress. Prostaglandins Leukot. Essent. Fat. Acids 74 (2006), 149–156.
30. Johnston, D.T., 2010. Effects of Omega-3 EPA/DHA for Soldiers at Risk for Mood Disorders. ClinicalTrials.Gov NCT01216982.
31. Kalinic, D., Borovac, S.L., Jeroncic, A., Mimica, N., Dodig, G., Delas, I., Eicosapentaenoic acid in serum lipids could be inversely correlated with severity of clinical symptomatology in Croatian war veterans with posttraumatic stress disorder. Croat. MEd. J. 55 (2014), 27–37.
32. Kalinic, D., Borovac Stefanovic, L., Jeroncic, A., Mimica, N., Dodig, G., Delas, I., Eicosapentaenoic acid in serum lipids could be inversely correlated with severity of clinical symptomatology in Croatian war veterans with posttraumatic stress disorder. Croat. MEd. J. 55 (2014), 27–37.
33. Kawakita, E., Hashimoto, M., Shido, O., Docosahexaenoic acid promotes neurogenesis in vitro and in vivo. Neuroscience 139 (2006), 991–997.
34. Kessler, R.C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K.R., Rush, A.J., Walters, E.E., Wang, P.S., The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289 (2003), 3095–3105.
35. Kessler, R.C., Petukhova, M., Sampson, N.A., Zaslavsky, A.M., Wittchen, H.U., Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int. J. Methods Psychiatr. Res 21 (2012), 169–184.
36. Kubzansky, L.D., Koenen, K.C., Spiro, A. III, Vokonas, P.S., Sparrow, D., Prospective study of posttraumatic stress disorder symptoms and coronary heart disease in the Normative Aging Study. Arch. Gen. Psychiatry 64 (2007), 109–116.
37. Lafourcade, M., Larrieu, T., Mato, S., Duffaud, A., Sepers, M., Matias, I., De Smedt-Peyrusse, V., Labrousse, V.F., Bretillon, L., Matute, C., Rodriguez-Puertas, R., Laye, S., Manzoni, O.J., Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Nat. Neurosci. 14 (2011), 345–350.
38. Laryea, M.D., Jiang, Y.F., Xu, G.L., Lombeck, I., Fatty acid composition of blood lipids in Chinese children consuming high erucic acid rapeseed oil. Ann. Nutr. Metab. 36 (1992), 273–278.
39. Lin, P.Y., Huang, S.Y., Su, K.P., A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biol. Psychiatry 68 (2010), 140–147.
40. Mahan, A.L., Ressler, K.J., Fear conditioning, synaptic plasticity and the amygdala: implications for posttraumatic stress disorder. Trends Neurosci. 35 (2012), 24–35.
41. Marriott, B., The Better Resiliency Among Veterans With Omega-3's (BRAVO) Study. Clin. Gov. NCT0, 2013, 1901887.
42. Marsicano, G., Wotjak, C.T., Azad, S.C., Bisogno, T., Rammes, G., Cascio, M.G., Hermann, H., Tang, J., Hofmann, C., Zieglgansberger, W., Di, M., Lutz, B, V., The endogenous cannabinoid system controls extinction of aversive memories. Nature 418 (2002), 530–534.
43. Martins, J.G., EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials. J. Am. Coll. Nutr. 28 (2009), 525–542.
44. Matsumoto, C., Matthan, N.R., Lichtenstein, A.H., Gaziano, J.M., Djousse, L., Red blood cell MUFAs and risk of coronary artery disease in the Physicians' Health Study. Am. J. Clin. Nutr. 98 (2013), 749–754.
45. Matsumura, K., Noguchi, H., Nishi, D., Matsuoka, Y., The effect of omega-3 fatty acids on psychophysiological assessment for the secondary prevention of posttraumatic stress disorder: an open-label pilot study. Glob. J. Health Sci. 4 (2012), 3–9.
46. Matsuoka, Y., Nishi, D., Hamazaki, K., Serum levels of polyunsaturated fatty acids and the risk of posttraumatic stress disorder. Psychother. Psychosom. 82 (2013), 408–410.
47. Matsuoka, Y., Nishi, D., Hamazaki, K., Yonemoto, N., Matsumura, K., Noguchi, H., Hashimoto, K., Hamazaki, T., Docosahexaenoic acid for selective prevention of posttraumatic stress disorder among severely injured patients: a randomized, placebo-controlled trial. J. Clin. Psychiatry 76 (2015), e1015–e1022.
48. Matsuoka, Y., Nishi, D., Nakaya, N., Sone, T., Hamazaki, K., Hamazaki, T., Koido, Y., Attenuating posttraumatic distress with omega-3 polyunsaturated fatty acids among disaster medical assistance team members after the Great East Japan Earthquake: the APOP randomized controlled trial. BMC. Psychiatry, 11, 2011, 132.
49. Matsuoka, Y., Nishi, D., Tanima, Y., Itakura, M., Kojima, M., Hamazaki, K., Noguchi, H., Hamazaki, T., Serum pro-BDNF/BDNF as a treatment biomarker for response to docosahexaenoic acid in traumatized people vulnerable to developing psychological distress: a randomized controlled trial. Transl. Psychiatry, 5, 2015, e596.
50. Matsuoka, Y., Nishi, D., Yonemoto, N., Hamazaki, K., Hashimoto, K., Hamazaki, T., Omega-3 fatty acids for secondary prevention of posttraumatic stress disorder after accidental injury: an open-label pilot study. J. Clin. Psychopharmacol. 30 (2010), 217–219.
51. Matsuoka, Y., Nishi, D., Yonemoto, N., Hamazaki, K., Matsumura, K., Noguchi, H., Hashimoto, K., Hamazaki, T., Tachikawa project for prevention of posttraumatic stress disorder with polyunsaturated fatty acid (TPOP): study protocol for a randomized controlled trial. BMC. Psychiatry, 13, 2013, 8.
52. McNamara, R.K., Deciphering the role of docosahexaenoic acid in brain maturation and pathology with magnetic resonance imaging. Prostaglandins Leukot. Essent. Fat. Acids 88 (2013), 33–42.
53. Medema, S., Mocking, R.J., Koeter, M.W., Vaz, F.M., Meijer, C., de Haan, L., van Beveren, N.J., for, G., aGenetic, R., Outcome of Psychosis, i., Kahn, R., de Haan, L., van Os, J., Wiersma, D., Bruggeman, R., Cahn, W., Meijer, C., Myin-Germeys, I., 2015. Levels of Red Blood Cell Fatty Acids in Patients With Psychosis, Their Unaffected Siblings, and Healthy Controls. Schizophr. Bull.
54. Meijerink, J., Balvers, M., Witkamp, R., N-acyl amines of docosahexaenoic acid and other n-3 polyunsatured fatty acids - from fishy endocannabinoids to potential leads. Br. J. Pharm. 169 (2013), 772–783.
55. Michels, L., Schulte-Vels, T., Schick, M., O'Gorman, R.L., Zeffiro, T., Hasler, G., Mueller-Pfeiffer, C., Prefrontal GABA and glutathione imbalance in posttraumatic stress disorder: Preliminary findings. Psychiatry Res 224 (2014), 288–295.
56. Miller, M.W., Sadeh, N., Traumatic stress, oxidative stress and post-traumatic stress disorder: neurodegeneration and the accelerated-aging hypothesis. Mol. Psychiatry 19 (2014), 1156–1162.
57. Mocking, R.J., Assies, J., Lok, A., Ruhe, H.G., Koeter, M.W., Visser, I., Bockting, C.L., Schene, A.H., Statistical methodological issues in handling of fatty acid data: percentage or concentration, imputation and indices. Lipids 47 (2012), 541–547.
58. R.J., Mocking, H.G., Ruhe, J., Assies, A., Lok, M.W., Koeter, I., Visser, C.L., Bockting, A.H., Schene, 2013a. Relationship between the hypothalamic-pituitary-adrenal-axis and fatty acid metabolism in recurrent depression. Psychoneuroendocrinology.
59. Mocking, R.J., Ruhé, H.G., Assies, J., Lok, A., Koeter, M.W., Visser, I., Bockting, C.L., Schene, A.H., Relationship between the hypothalamic-pituitary-adrenal-axis and fatty acid metabolism in recurrent depression. Psychoneuroendocrinology 38 (2013), 1607–1617.
60. Mocking, R.J., Verburg, H.F., Westerink, A.M., Assies, J., Vaz, F.M., Koeter, M.W., Ruhe, H.G., Schene, A.H., Fatty acid metabolism and its longitudinal relationship with the hypothalamic-pituitary-adrenal axis in major depression: Associations with prospective antidepressant response. Psychoneuroendocrinology 59 (2015), 1–13.
61. Mocking, R.J.T.H.,I., Assies, J., Koeter, M.W.J., Ruhé, H.G., Schene, A.H., Meta-Analysis and Meta-Regression of Omega-3 polyunsaturated fatty acid supplementation for major depressive disorder. Transl. Psychiatry, 2016.
62. Mouthaan, J., Sijbrandij, M., Luitse, J.S., Goslings, J.C., Gersons, B.P., Olff, M., The role of acute cortisol and DHEAS in predicting acute and chronic PTSD symptoms. Psychoneuroendocrinology 45 (2014), 179–186.
63. Naylor, J., Marx, C.E., Clinical Trial: Omega-3 Fatty Acids and Post Traumatic Stress Disorder (PTSD). Clin. Gov., 2013.
64. Neumeister, A., The endocannabinoid system provides an avenue for evidence-based treatment development for PTSD. Depress Anxiety 30 (2013), 93–96.
65. Ng, F., Berk, M., Dean, O., Bush, A.I., Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int. J. Neuropsychopharmacol. 11 (2008), 851–876.
66. Nishi, D., Koido, Y., Nakaya, N., Sone, T., Noguchi, H., Hamazaki, K., Hamazaki, T., Matsuoka, Y., Fish oil for attenuating posttraumatic stress symptoms among rescue workers after the great east Japan earthquake: a randomized controlled trial. Psychother. Psychosom. 81 (2012), 315–317.
67. M., Olff, J.L., Frijling, L.D., Kubzansky, B., Bradley, M.A., Ellenbogen, C., Cardoso, J.A., Bartz, J.R., Yee, Z.M., van, 2013. The role of oxytocin in social bonding, stress regulation and mental health: An update on the moderating effects of context and interindividual differences. Psychoneuroendocrinology.
68. Olff, M., Guzelcan, Y., de Vries, G.J., Assies, J., Gersons, B.P., HPA- and HPT-axis alterations in chronic posttraumatic stress disorder. Psychoneuroendocrinology 31 (2006), 1220–1230.
69. Park, Y., Kim, M., Baek, D., Kim, S.H., Erythrocyte n-3 polyunsaturated fatty acid and seafood intake decrease the risk of depression: case-control study in Korea. Ann. Nutr. Metab. 61 (2012), 25–31.
70. M.A., Penzo, V., Robert, J., Tucciarone, B.D., De, M., Wang, A.L., Van, M., Darvas, L.F., Parada, R.D., Palmiter, M., He, Z.J., Huang, B., Li, 2015. The paraventricular thalamus controls a central amygdala fear circuit. Nature.
71. Peters, B.D., Machielsen, M.W., Hoen, W.P., Caan, M.W., Malhotra, A.K., Szeszko, P.R., Duran, M., Olabarriaga, S.D., de, H.L., Polyunsaturated fatty acid concentration predicts myelin integrity in early-phase psychosis. Schizophr. Bull. 39 (2013), 830–838.
72. Pitman, R.K., Rasmusson, A.M., Koenen, K.C., Shin, L.M., Orr, S.P., Gilbertson, M.W., Milad, M.R., Liberzon, I., Biological studies of post-traumatic stress disorder. Nat. Rev. Neurosci. 13 (2012), 769–787.
73. Pottala, J.V., Talley, J.A., Churchill, S.W., Lynch, D.A., von, S.C., Harris, W.S., Red blood cell fatty acids are associated with depression in a case-control study of adolescents. Prostaglandins Leukot. Essent. Fat. Acids 86 (2012), 161–165.
74. Ramsden, C.E., Zamora, D., Leelarthaepin, B., Majchrzak-Hong, S.F., Faurot, K.R., Suchindran, C.M., Ringel, A., Davis, J.M., Hibbeln, J.R., Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ, 346, 2013, e8707.
75. Rao, J.S., Ertley, R.N., Lee, H.J., DeMar, J.C. Jr., Arnold, J.T., Rapoport, S.I., Bazinet, R.P., n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism. Mol. Psychiatry 12 (2007), 36–46.
76. Rohleder, N., Schommer, N.C., Hellhammer, D.H., Engel, R., Kirschbaum, C., Sex differences in glucocorticoid sensitivity of proinflammatory cytokine production after psychosocial stress. Psychosom. MEd 63 (2001), 966–972.
77. Rosenbaum, P.R., Rubin, D.B., The Central Role of the Propensity Score in Observational Studies for Causal Effects. Biometrika 70 (1983), 41–55.
78. Samieri, C., Maillard, P., Crivello, F., Proust-Lima, C., Peuchant, E., Helmer, C., Amieva, H., Allard, M., Dartigues, J.F., Cunnane, S.C., Mazoyer, B.M., Barberger-Gateau, P., Plasma long-chain omega-3 fatty acids and atrophy of the medial temporal lobe. Neurology 79 (2012), 642–650.
79. Southwick, S.M., Bonanno, G.A., Masten, A.S., Panter-Brick, C., Yehuda, R., Resilience definitions, theory, and challenges: interdisciplinary perspectives. Eur. J. Psychotraumatol, 2014, 5.
80. Sun, Q., Ma, J., Campos, H., Hankinson, S.E., Hu, F.B., Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women. Am. J. Clin. Nutr. 86 (2007), 74–81.
81. Thompson, F., Subar, A., Dietary Assessment Methodology. Coulston, A., Boushey, C., Ferruzzi, M., (eds.) Nutrition in the prevention and Treatment of Disease, 3d ed, 2013, Academic Press, London, 5–46.
82. Tsaluchidu, S., Cocchi, M., Tonello, L., Puri, B.K., Fatty acids and oxidative stress in psychiatric disorders. Bmc. Psychiatry, 8(Suppl 1), 2008, S5.
83. Vaccarino, V., Goldberg, J., Rooks, C., Shah, A.J., Veledar, E., Faber, T.L., Votaw, J.R., Forsberg, C.W., Bremner, J.D., Post-traumatic stress disorder and incidence of coronary heart disease: a twin study. J. Am. Coll. Cardiol. 62 (2013), 970–978.
84. Vemuri, M., Kelley, D.S., The Effects of Dietary Fatty Acids on Lipid Metabolism. Chow, C.K., (eds.) Fatty Acids in Foods and Their Health Implications, 3rd ed, 2008, CRC Press, Taylor and Francis, Boca Raton, FL, 591–630.
85. Voedingscentrum, 2006. NEVO-tabel: Nederlands Voedingsstoffenbestand/ Stichting Nederlands Voedingsstoffenbestand. Voedingscentrum, Den Haag.
86. Wittchen, H.U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jonsson, B., Olesen, J., Allgulander, C., Alonso, J., Faravelli, C., Fratiglioni, L., Jennum, P., Lieb, R., Maercker, A., van, O.J., Preisig, M., Salvador-Carulla, L., Simon, R., Steinhausen, H.C., The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur. Neuropsychopharmacol. 21 (2011), 655–679.
87. Wu, A., Ying, Z., Gomez-Pinilla, F., Docosahexaenoic acid dietary supplementation enhances the effects of exercise on synaptic plasticity and cognition. Neuroscience 155 (2008), 751–759.
88. Yehuda, R., Kahana, B., Binder-Brynes, K., Southwick, S.M., Mason, J.W., Giller, E.L., Low urinary cortisol excretion in Holocaust survivors with posttraumatic stress disorder. Am. J. Psychiatry 152 (1995), 982–986.
89. Zeev, K., Michael, M., Ram, K., Hagit, C., Possible deleterious effects of adjunctive omega-3 fatty acids in post-traumatic stress disorder patients. Neuropsychiatr. Dis. Treat. 1 (2005), 187–190.
90. Zhang, L., Benedek, D.M., Fullerton, C.S., Forsten, R.D., Naifeh, J.A., Li, X.X., Hu, X.Z., Li, H., Jia, M., Xing, G.Q., Benevides, K.N., Ursano, R.J., PTSD risk is associated with BDNF Val66Met and BDNF overexpression. Mol. Psychiatry 19 (2014), 8–10.